Dabigatran, a distinguished member of the direct oral anticoagulant (DOAC) family, has revolutionized anticoagulation therapy. Specifically designed to mitigate the risk of stroke and systemic embolism, dabigatran stands out for its application in individuals with non-valvular atrial fibrillation. In this exploration, we delve deeper into the unique characteristics of dabigatran that...